Dimensional Fund Advisors
ARTV

Dimensional Fund Advisors’s Artiva Biotherapeutics ARTV Stock Holding History

Dimensional Fund Advisors’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$435K Buy
44,815
+24,445
+120% +$223K ﹤0.01% 2983
2026
Q1 		$131K Buy
+20,370
New +$101K ﹤0.01% 3098

Other funds holding ARTV

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Dimensional Fund Advisors's ARTV Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Artiva Biotherapeutics (ARTV) stake by 120% in Q2 2026, buying an estimated $223K and bringing the position to 44,815 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

Dimensional Fund Advisors first reported a position in ARTV in Q1 2026 and has held it in 2 quarters since. 72 funds tracked by Wall St. Rank hold ARTV as of Q2 2026.

  • Dimensional Fund Advisors held 44,815 shares of Artiva Biotherapeutics worth $435K as of Q2 2026.
  • Dimensional Fund Advisors bought 24,445 Artiva Biotherapeutics shares in Q2 2026, an estimated $223K.
  • Artiva Biotherapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2983 holding.
  • Dimensional Fund Advisors first reported a position in Artiva Biotherapeutics in Q1 2026 and has held it in 2 quarters since.
  • 72 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.